2,018
Views
29
CrossRef citations to date
0
Altmetric
Review

Factors Related to Severity of Diabetic Foot Ulcer: A Systematic Review

ORCID Icon, ORCID Icon &
Pages 1835-1842 | Published online: 25 May 2020

References

  • Ramachandran A, Snehalatha C, Shetty AS, Nanditha A. Trends in prevalence of diabetes in Asian countries. World J Diabetes. 2012;3(6):110. doi:10.4239/wjd.v3.i6.110
  • Shahbazian H, Yazdanpanah L, Latifi SM. Risk assessment of patients with diabetes for foot ulcers according to risk classification consensus of International Working Group on Diabetic Foot (IWGDF). Pak J Med Sci. 2013;29(3):730. doi:10.12669/pjms.293.3473
  • IDF Diabetes Atlas 9th edition; 2019. Available from: https://diabetesatlas.org/en/. Accessed Dec 13, 2019.
  • Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4–14. doi:10.1016/j.diabres.2009.10.007
  • Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94(3):311–321. doi:10.1016/j.diabres.2011.10.029
  • Hamano K, Nakadaira I, Suzuki J, Gonai M. N-terminal fragment of probrain natriuretic peptide is associated with diabetes microvascular complications in type 2 diabetes. Vasc Health Risk Manag. 2014;10:585–589. doi:10.2147/VHRM.S67753
  • Choudhry Abid Nazir S, Nawaz R. Severity and outcome of patients presenting with diabetic foot at Tertiary Care Center at Gujrat. Pakistan Journal of Medical and Health Sciences. 2019;13(4):1024–1026
  • Bakker K, Apelqvist J, Lipsky BA, Van Netten JJ. The 2015 IWGDF guidance documents on prevention and management of foot problems in diabetes: development of an evidence-based global consensus. Diabetes Metab Res Rev. 2016;32(Suppl 1):2–6. doi:10.1002/dmrr.2694
  • Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293(2):217–228. doi:10.1001/jama.293.2.217
  • Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Ann Med. 2017;49(2):106–116. doi:10.1080/07853890.2016.1231932
  • Meidani M, Khorvash F, Rajabpournikfam MR. The relationship between controlling HbA1C and infected diabetic foot ulcer. J Isfahan Med Sch. 2012;30.
  • Shahi SK, Kumar A, Kumar S, Singh SK. Prevalence of diabetic foot ulcer and associated risk factors in diabetic patients from North India. J Diabetic Foot Complications. 2012;4(3):83–91.
  • Mariam TG, Alemayehu A, Tesfaye E, et al. Prevalence of diabetic foot ulcer and associated factors among adult diabetic patients who attend the diabetic follow-up clinic at the University of Gondar Referral Hospital, North West Ethiopia, 2016: institutional-Based Cross-Sectional Study. J Diabetes Res. 2017;2017.
  • Bakri FG, Allan AH, Khader YS, Younes NA, Ajlouni KM. Prevalence of diabetic foot ulcer and its associated risk factors among diabetic patients in Jordan. Jordan Med J. 2012;171(785):1–16.
  • Taghipour M, Abi Kordadeh E, Eslami M. Review of biomechanical parameters of diabetic foot ulcers. Razi J Med Sci. 2016;23(144):51–67.
  • Ochoa-Gonzalez F, Cervantes-Villagrana AR, Fernandez-Ruiz JC, et al. Metformin induces cell cycle arrest, reduced proliferation, wound healing impairment in vivo and is associated to clinical outcomes in diabetic foot ulcer patients. PLoS One. 2016;11:3.
  • Assaad-Khalil S, Zaki A, Rehim AA, et al. Prevalence of diabetic foot disorders and related risk factors among Egyptian subjects with diabetes. Prim Care Diabetes. 2015;9(4):297–303. doi:10.1016/j.pcd.2014.10.010
  • Brennan MB, Hess TM, Bartle B, et al. Diabetic foot ulcer severity predicts mortality among veterans with type 2 diabetes. J Diabetes Complications. 2017;31(3):556–561. doi:10.1016/j.jdiacomp.2016.11.020
  • Rice JB, Desai U, Cummings AK, Birnbaum HG, Skornicki M, Parsons NB. Burden of diabetic foot ulcers for medicare and private insurers. Diabetes Care. 2014;37(3):651–658. doi:10.2337/dc13-2176
  • Beckert S, Witte M, Wicke C, Königsrainer A, Coerper S. A new wound-based severity score for diabetic foot ulcers. Diabetes Care. 2006;29(5):988. doi:10.2337/dc05-2431
  • Menezes JVF, Sreenidhi G. Clinical utility of diabetic ulcer severity score in surgical practice. Int J Surg. 2019;6(7):2469–2474. doi:10.18203/2349-2902.isj20192976
  • Apelqvist J, Agardh CD, Castenfors J, Larsson J, Stenström A. Wound classification is more important than site of ulceration in the outcome of diabetic foot ulcers. Diabetic Med. 1989;6(6):526–530. doi:10.1111/j.1464-5491.1989.tb01221.x
  • Marzoq A, Shiaa N, Zaboon R, Baghlany Q, Alabbood MH. Assessment of the outcome of diabetic foot ulcers in Basrah, Southern Iraq: a cohort study. Int J Diabetes Metab. 2019;25(1–2):33–38. doi:10.1159/000500911
  • Yazdanpanah L, Nasiri M, Adarvishi S. Literature review on the management of diabetic foot ulcer. World J Diabetes. 2015;6(1):37. doi:10.4239/wjd.v6.i1.37
  • Schaper NC, van Netten JJ, Apelqvist J, et al. Practical guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36:e3266. doi:10.1002/dmrr.3266
  • Zhang -S-S, Tang Z-Y, Fang P, Qian H-J, Xu L, Ning G. Nutritional status deteriorates as the severity of diabetic foot ulcers increases and independently associates with prognosis. Exp Ther Med. 2013;5(1):215–222. doi:10.3892/etm.2012.780
  • Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi:10.1371/journal.pmed.1000097
  • Moeini M, Shahriari M, Yousefi H, Esfandiari G, Babaahmadi M. An investigation on the wound severity and its association with predisposing factors in patients with diabetic foot. J Clin Nurs Midwifery. 2017;5(4):67–75.
  • Madmoli M, Madmoli Y, Taqvaeinasab H, Khodadadi M, Darabiyan P, Rafi A. Some influential factors on severity of diabetic foot ulcers and Predisposing of limb amputation: a 7-year study on diabetic patients. Int J Ayurvedic Med. 2019;10(1):75–81.
  • Wagner FW Jr. The dysvascular foot: a system for diagnosis and treatment. Foot Ankle. 1981;2(2):64–122. doi:10.1177/107110078100200202
  • Lavery LA, Armstrong DG, Harkless LB. Classification of diabetic foot wounds. J Foot Ankle Surg. 1996;35(6):528–531. doi:10.1016/S1067-2516(96)80125-6
  • Armstrong DG, Lavery LA, Harkless LB. Validation of a diabetic wound classification system: the contribution of depth, infection, and ischemia to risk of amputation. Diabetes Care. 1998;21(5):855–859. doi:10.2337/diacare.21.5.855
  • Winkley K, Stahl D, Chalder T, Edmonds ME, Ismail K. Risk factors associated with adverse outcomes in a population-based prospective cohort study of people with their first diabetic foot ulcer. J Diabetes Complications. 2007;21(6):341–349. doi:10.1016/j.jdiacomp.2007.09.004
  • Ghobadi A, Sarbarzeh P, Jalilian M, Abdi A, Manouchehri S. Evaluation of factors affecting the severity of diabetic foot ulcer in patients with diabetes referred to a diabetes centre in Kermanshah. Diabetes Metab Syndr Obes. 2020;13:693–703. doi:10.2147/DMSO.S242431
  • Holzer SES, Camerota A, Martens L, Cuerdon T, Crystal-Peters J, Zagari M. Costs and duration of care for lower extremity ulcers in patients with diabetes. Clin Ther. 1998;20(1):169–181. doi:10.1016/S0149-2918(98)80044-1
  • Smith-Strøm H, Iversen MM, Igland J, et al. Severity and duration of diabetic foot ulcer (DFU) before seeking care as predictors of healing time: a retrospective cohort study. PLoS One. 2017;12(5):e0177176. doi:10.1371/journal.pone.0177176
  • Mir K, Pugazhendhi S, Paul M, Nair A, Ramakrishna B. Heat‐shock protein 70 gene polymorphism is associated with the severity of diabetic foot ulcer and the outcome of surgical treatment. Br J Surg. 2009;96(10):1205–1209. doi:10.1002/bjs.6689
  • Alavi A, Sibbald RG, Mayer D, et al. Diabetic foot ulcers: part I. Pathophysiology and prevention. J Am Acad Dermatol. 2014;70(1):1. e1-1. e18. doi:10.1016/j.jaad.2013.06.055
  • Gordois A, Scuffham P, Shearer A, Oglesby A. The healthcare costs of diabetic peripheral neuropathy in the UK. Diabet Foot. 2003;6:62–73.
  • Gordois A, Scuffham P, Shearer A, Oglesby A, Tobian JA. The health care costs of diabetic peripheral neuropathy in the US. Diabetes Care. 2003;26(6):1790–1795. doi:10.2337/diacare.26.6.1790
  • Almobarak AO, Awadalla H, Osman M, Ahmed MH. Prevalence of diabetic foot ulceration and associated risk factors: an old and still major public health problem in Khartoum, Sudan? Ann Transl Med. 2017;5(17):340. doi:10.21037/atm.2017.07.01
  • Ogbera A, Fasanmade O, Ohwovoriole A, Adediran O. An assessment of the disease burden of foot ulcers in patients with diabetes mellitus attending a teaching hospital in Lagos, Nigeria. Int J Low Extrem Wounds. 2006;5(4):244–249. doi:10.1177/1534734606294538
  • Nyamu P, Otieno C, Amayo E, McLigeyo S. Risk factors and prevalence of diabetic foot ulcers at Kenyatta National Hospital, Nairobi. East Afr Med J. 2003;80(1):36–43. doi:10.4314/eamj.v80i1.8664
  • Widatalla AH, Mahadi SEI, Shawer MA, Elsayem HA, Ahmed ME. Implementation of diabetic foot ulcer classification system for research purposes to predict lower extremity amputation. Int J Diabetes Dev Ctries. 2009;29(1):1. doi:10.4103/0973-3930.50707
  • Abetz L, Sutton M, Brady L, McNulty P, Gagnon DD. The Diabetic Foot Ulcer Scale (DFS): a quality of life instrument for use in clinical trials. Pract Diabetes Int. 2002;19(6):167–175. doi:10.1002/pdi.356
  • Aragón-Sánchez J. Clinical–pathological characterization of diabetic foot infections: grading the severity of osteomyelitis. Int J Low Extrem Wounds. 2012;11(2):107–112. doi:10.1177/1534734612447617
  • Davies M, Brophy S, Williams R, Taylor A. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care. 2006;29(7):1518–1522. doi:10.2337/dc05-2228
  • Harding JL, Pavkov ME, Magliano DJ, Shaw JE, Gregg EW. Global trends in diabetes complications: a review of current evidence. Diabetologia. 2019;62(1):3–16. doi:10.1007/s00125-018-4711-2
  • Mauricio D, Alonso N, Gratacòs M. Chronic diabetes complications: the need to move beyond classical concepts. Trends Endocrinol Metab. 2020;31(4):287–295. doi:10.1016/j.tem.2020.01.007
  • Machado C, Teixeira S, Fonseca L, et al. Evolutionary trends in bacteria isolated from moderate and severe diabetic foot infections in a Portuguese tertiary center. Diabetes Metab Syndr. 2020;14(3):205–209. doi:10.1016/j.dsx.2020.02.010
  • Welty FK, Alfaddagh A, Elajami TK. Targeting inflammation in metabolic syndrome. Transl Res. 2016;167(1):257–280. doi:10.1016/j.trsl.2015.06.017
  • Hao D, Hu C, Zhang T, Feng G, Chai J, Li T. Contribution of infection and peripheral artery disease to severity of diabetic foot ulcers in Chinese patients. Int J Clin Pract. 2014;68(9):1161–1164. doi:10.1111/ijcp.12440